Cargando…

Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review

N-Acetylcysteine (NAC) is widely used in respiratory medicine, with a maximum licensed dose in chronic use of 600 mg/day; however, some clinical trials have studied the efficacy of NAC at higher doses. The aim of this review was to evaluate the adverse effects profile of NAC at higher than the stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Calverley, Peter, Rogliani, Paola, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892733/
https://www.ncbi.nlm.nih.gov/pubmed/33326056
http://dx.doi.org/10.1007/s40264-020-01026-y